| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRIM.2008.12.001 |
| P698 | PubMed publication ID | 19146957 |
| P2093 | author name string | Jun Liu | |
| Yong Zhao | |||
| Chun Zeng | |||
| Aijun Zhang | |||
| Yanyan Qu | |||
| Aqeel Javeed | |||
| Baojun Zhang | |||
| Lianjun Zhang | |||
| Chenming Sun | |||
| P2860 | cites work | Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells | Q24683705 |
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| What are all the things that aspirin does? | Q28165288 | ||
| Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation | Q28169139 | ||
| Selective inhibition of interleukin-4 gene expression in human T cells by aspirin | Q28176676 | ||
| Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells | Q28184794 | ||
| Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2 | Q28188067 | ||
| Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells | Q28192501 | ||
| Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events | Q28193991 | ||
| Aspirin and mortality from coronary bypass surgery | Q28194029 | ||
| Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis | Q28194233 | ||
| Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells | Q28196391 | ||
| Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice | Q28198817 | ||
| Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells | Q28199779 | ||
| Aspirin induces apoptosis through the inhibition of proteasome function | Q28199915 | ||
| Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages | Q28210495 | ||
| Inhibition of NF-kappa B by sodium salicylate and aspirin | Q29614708 | ||
| The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta | Q29617188 | ||
| Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
| Regulatory T cells in the control of immune pathology. | Q34348983 | ||
| Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance | Q34448410 | ||
| Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. | Q34518941 | ||
| Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome | Q34546348 | ||
| The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road | Q34575923 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 | Q34803113 | ||
| Regulatory T cells and mechanisms of immune system control | Q35852343 | ||
| Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells | Q40395279 | ||
| Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 | ||
| Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer | Q46549031 | ||
| Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation | Q47579275 | ||
| Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death | Q48020712 | ||
| Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. | Q51980708 | ||
| Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. | Q53564968 | ||
| A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. | Q53583176 | ||
| Presence of functional mouse regulatory CD4+CD25+T cells in xenogeneic neonatal porcine thymus-grafted athymic mice. | Q53591791 | ||
| Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. | Q53674506 | ||
| Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
| CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
| FOXP3+CD4+CD25+ Adaptive Regulatory T Cells Express Cyclooxygenase-2 and Suppress Effector T Cells by a Prostaglandin E2-Dependent Mechanism | Q58123220 | ||
| IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
| Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus | Q61050853 | ||
| CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance | Q61053435 | ||
| Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin | Q73023986 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice | Q79780581 | ||
| The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases | Q80636937 | ||
| P433 | issue | 4 | |
| P921 | main subject | aspirin | Q18216 |
| P304 | page(s) | 253-260 | |
| P577 | publication date | 2009-01-13 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice | |
| P478 | volume | 20 |
| Q36345775 | Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. |
| Q90150182 | Effect of selected non-steroidal anti-inflammatory drugs on activation-induced CD25 expression on murine CD4+ and CD8+ T cells: an in vitro study |
| Q39018591 | Foxp3, Regulatory T Cell, and Autoimmune Diseases |
| Q36958891 | In vitro effects of meloxicam on the number, Foxp3 expression, production of selected cytokines, and apoptosis of bovine CD25+CD4+ and CD25-CD4+ cells |
| Q87863599 | In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs |
| Q30409790 | Regulatory T cells in AKI. |
| Q26798141 | Research Progress on Regulatory T Cells in Acute Kidney Injury |
| Q91596480 | Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer |
Search more.